SCHEMBL19851002

SCHEMBL19851002

Fc1ccc(Nc2nc(-c3ccccc3)cs2)c(F)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.70
KMT2A Q03164 8/20 0.70
SMN1; SMN2 Q16637 6/20 0.70
MAPT P10636 5/20 0.70
MAPK1 P28482 1/20 0.70
RECQL P46063 1/20 0.70
CTRB1 P17538 1/20 0.69
CTRC Q99895 1/20 0.69
NPY5R Q15761 1/20 0.62
CYP1A1 P04798 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP1B1 Q16678 1/20 0.58
CCR4 P51679 1/20 0.57
ROCK1 Q13464 1/20 0.56
NPC1 O15118 6/20 0.54
RAB9A P51151 6/20 0.54
SENP8 Q96LD8 1/20 0.53
SENP7 Q9BQF6 1/20 0.53
SENP6 Q9GZR1 1/20 0.53
PSMD14 O00487 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19839869 0.86 RAB9A (0.70) MEN1KMT2ASMN1; SMN2MAPTMAPK1
SCHEMBL23742583 0.85 CCR4 (0.67) MEN1KMT2ASMN1; SMN2MAPTRECQL
SCHEMBL19851003 0.83 CTRB1 (0.64) MEN1KMT2AMAPTCTRB1CTRC
SCHEMBL23742652 0.83 NPY5R (0.69) MEN1KMT2ASMN1; SMN2MAPTCTRB1
SCHEMBL23742582 0.82 CYP1A1 (0.57) MEN1KMT2ASMN1; SMN2MAPTMAPK1
SCHEMBL1820221 0.80 NPY5R (0.88) MEN1KMT2ASMN1; SMN2MAPTMAPK1
SCHEMBL7113430 0.80 NPY5R (0.57) MEN1KMT2ASMN1; SMN2MAPTMAPK1
SCHEMBL23742626 0.79 CYP1A1 (0.88) MEN1KMT2ASMN1; SMN2MAPTMAPK1
SCHEMBL28712020 0.77 CYP1A1 (0.68) MEN1KMT2ACTRB1CTRCCYP1A1
SCHEMBL1891977 0.77 ROCK1 (0.68) MEN1KMT2ASMN1; SMN2MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10947207-B2 GP130 modulators THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-03-16 US disclosed
US-10947207-B2 GP130 modulators THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-03-16 US disclosed
US-20190292161-A1 GP130 MODULATORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2019-09-26 US disclosed
US-20190292161-A1 GP130 MODULATORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2019-09-26 US disclosed
WO-2018027193-A1 GP130 MODULATORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292161-A1 GP130 MODULATORS GRIN2A, GRIA4, GRIA3 MEN1 4541/4885KMT2A 3926/4885SMN1; SMN2 758/4885
US-10947207-B2 GP130 modulators GRIN2A, GRIA4, GRIA3 MEN1 4541/4885KMT2A 3926/4885SMN1; SMN2 758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.